Tags |
|
|
Links |
|
|
Digg It - Don't Insult Me With Trial Closing Questions And Sales Closes
Today I received a cold call from a telemarketer to sell me a newspaper subscription. I found hi
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
s sales script quite amusing. Here's how it went:
"Good morning Mr. Buntic, I'm calling from th
"Good morning Mr. Buntic, I'm calling from th
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
e Toronto Star. Today I would like to ask you, when you start your new subscription to the Toron
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
to Star would you prefer it delivered to the front door or the back door?"
My reply:
"Hmmm, th
My reply:
"Hmmm, th
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
Toronto Star? Never heard of it. Tell me more about your newspaper."
Of course I was kidding.
Of course I was kidding.
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
Anybody that lives in Toronto knows what the Toronto Star is. It is one of the two major Toronto
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
dailies. This telemarketer from the newspaper decided to use sales closes and trial closing que
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
tions right off the bat so in return I played around with him. People that use sales closing tec
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
hniques assume that they can outsmart the prospect. Really, that's all that sales closes are, a
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
way to try to outsmart your target. That’s what this telemarketer believed he could do to me.
R
R
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ading this, you can see how absurd this telemarketer's techniques were. So, if you are a salespe
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
rson, would you use these techniques? Would it not worry you that your prospect might see throug
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
h you just like you see through this telemarketer? Do you think it’s possible that your prospect
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
may think you’re just absurd as you think this telemarketer is?
Assume that the prospects you
Assume that the prospects you
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ell to know the exact same techniques that you use. Would you use these techniques then? Since a
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ll of the sales closing techniques that you know probably come from a bestselling sales book tha
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
t millions of other business professionals have read, then it's quite likely that they will know
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
exactly what you’re trying to do and your techniques will be rendered meaningless.
So, if you a
So, if you a
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
re in sales, don't try to outsmart your prospects. Trial closing questions and sales closes are
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
meaningless.
By the way, who gets their paper delivered to the back door? What’s that all about
By the way, who gets their paper delivered to the back door? What’s that all about
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/39070/diggit-Dont-Insult-Me-With-Trial-Closing-Questions-And-Sales-Closes.html">Don't Insult Me With Trial Closing Questions And Sales Closes</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/39070/diggit-Dont-Insult-Me-With-Trial-Closing-Questions-And-Sales-Closes.html]Don't Insult Me With Trial Closing Questions And Sales Closes[/url]
Related Articles:
Bookmark it:
|